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OBJECTIVES We sought to compare the characteristics and outcomes of patients with acute myocardial
infarction (MI) and cardiogenic shock (CS) caused by rupture of the ventricular free wall or
tamponade versus shock from other causes.
BACKGROUND Free-wall rupture is a recognized cause of mortality in patients with acute MI. Some of these
patients present subacutely, which provides an opportunity for intervention. Recognition of
factors that distinguish them from the overall shock cohort would be beneficial.
METHODS The international SHOCK Trial Registry enrolled patients concurrently with the randomized
SHOCK Trial. Thirty-six centers consecutively enrolled all patients with suspected CS after
MI, regardless of trial eligibility.
RESULTS Of the 1,048 patients studied, 28 (2.7%) had free-wall rupture or tamponade. These patients
had less pulmonary edema, less diabetes, less prior MI, and less prior congestive heart failure
(all p , 0.05). They more often had new Q waves in two or more leads (51.9% vs. 31.5%, p ,
0.04), but MI location and time to shock onset after MI did not differ. Of patients with
rupture or tamponade, 75% had pericardial effusions. No hemodynamic characteristics
identified patients with rupture/tamponade. Most patients with rupture/tamponade had
surgery and/or pericardiocentesis (27/28); their in-hospital survival rate was identical to that
of the group overall (39.3%). Women and older patients with rupture/tamponade tended to
survive intervention less often.
CONCLUSIONS Free-wall rupture and tamponade may present as CS after MI, and survival after intervention
is similar to that of the overall shock cohort. All patients with CS after MI should have
echocardiography in order to detect subacute rupture or tamponade and initiate appropriate
interventions. (J Am Coll Cardiol 2000;36:1117–22) © 2000 by the American College of
Cardiology
Rupture of the ventricular free wall, a dramatic clinical
event, is an uncommon but not rare cause of death in
patients hospitalized with acute myocardial infarction (MI)
(1,2). Its overall incidence is estimated to be about 6%, but
it accounts for as much as 15% of the in-hospital mortality
after MI (3,4). Late administration of thrombolytic therapy,
large infarctions, advanced age and female gender are
known risk factors for rupture (5–8).
Many patients succumb almost instantaneously with
rapid, irreversible, electromechanical dissociation, but oth-
ers present with a less acute clinical course, which, when
recognized, allows for potentially life-saving therapeutic
intervention (9). These patients often present with hypo-
tension and other signs of cardiogenic shock (CS) (10,11).
It is therefore important to attempt to distinguish free-wall
rupture and tamponade from the spectrum of patients
developing CS after MI.
The recent SHould we emergently revascularize Oc-
cluded Coronaries for cardiogenic shocK? (SHOCK) Trial
(12) concurrently compiled an international registry of
patients who developed CS after MI. The SHOCK Trial
Registry allowed us to identify patients with CS after
free-wall rupture and compare their presentation, course
and outcomes with those of the range of patients who
develop CS in the setting of acute MI.
METHODS
Study population. The SHOCK Trial Registry was initi-
ated to ensure that all potentially eligible patients were
considered for the randomized SHOCK Trial and to reduce
the possibility that an enrolling center was systematically
excluding a particular subgroup of patients from the Trial.
The Registry was maintained at all enrolling centers and
included all patients with suspected CS complicating acute
MI, regardless of trial eligibility. The Registry enrolled
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1,190 patients between April 1993 and September 1997.
Detailed Registry methodology is being reported in this
supplementary issue of the Journal (13). Institutional Re-
view Board approval was obtained at all enrolling centers
prior to commencing the recruitment.
Failure to meet all trial inclusion criteria, presentation
outside of the specified time period or inability to give
informed consent were reasons for enrollment in the Reg-
istry rather than the trial. Cardiogenic shock was considered
to be present if all the following conditions were met: 1)
systolic blood pressure (BP) persistently was ,90 mm Hg,
or vasopressors were required to maintain BP $90 mm Hg;
2) there was evidence of end-organ hypoperfusion, such as
altered mental status, cold or diaphoretic extremities, or low
urine output; 3) there was evidence of elevated filling
pressures (for example, pulmonary congestion at physical
examination or in chest radiograph or, if right-heart cath-
eterization had been performed, a capillary wedge pressure
of $15 mm Hg). Causes of CS other than predominant left
ventricular (LV) failure were recorded and they included
isolated right ventricular (RV) shock; acute, severe mitral
regurgitation (MR); ventricular septal rupture; free-wall
rupture or tamponade; and shock related to noncardiac
causes, such as hemorrhage or sepsis.
Patients locally diagnosed with free-wall rupture or tam-
ponade are the focus of this analysis. Patients with CS
complicated by rupture of the interventricular septum or
acute, severe MR (n 5 142) were excluded from the dataset
and are reported separately (14,15). Patients with free-wall
rupture or tamponade were compared with the larger cohort
of patients with CS from other causes (n 5 1,020), of which
primary LV failure (n 5 884) formed the largest group.
Statistical methods. The Fisher exact test was used to
examine the association between categorical variables and
diagnosis (presence or absence of rupture/tamponade). The
means of normally distributed variables were compared by
using the Student t-test. The distributions of skewed
variables were compared by using the Wilcoxon rank-sum
test. Multivariate modeling of mortality was not performed,
because of the small sample size of the rupture/tamponade
group. Descriptive statistics are expressed as mean 6 SD.
All p values are two-sided and considered statistically
significant at p , 0.05. No adjustments were made for
multiple univariate comparisons.
RESULTS
After excluding patients with CS secondary to septal rup-
ture or acute, severe MR, 28 patients in the remaining
cohort (n 5 1,048) had rupture or tamponade (2.7%). The
overall prevalence was 2.3% if all 1,190 patients in the
Registry were considered. The diagnosis was based on
echocardiographic findings or clinical presentation and con-
firmed at surgery or pericardiocentesis in 96% of the
patients. Of these 28 patients, 6 were characterized as
rupture alone, 9 as tamponade alone, and 13 as both rupture
and tamponade.
Clinical characteristics. Patients with rupture or tampon-
ade tended to be older and more commonly were female,
but these differences did not reach statistical significance
(Table 1). Patients with rupture or tamponade had signifi-
cantly less prior MI, congestive heart failure, diabetes and
peripheral vascular disease. At physical examination, pa-
tients with rupture or tamponade less often had pulmonary
edema (16.7% vs. 55.3%, p , 0.001). Patients with rupture
or tamponade more often showed new Q waves in two or
more leads (51.9% vs. 31.5%, p 5 0.035), but there was no
difference in MI location or development of ST-segment
elevation after the appearance of Q waves. The time from
MI onset to CS onset did not differ between the two groups
(median 12.0 h [interquartile range, 3.6 to 21.0 h] for the
rupture/tamponade group vs. 6.0 h [1.7 to 20.1 h] for the
other patients), and similar proportions of patients received
thrombolytic therapy (39.3% vs. 34.2%, p 5 ns). Adminis-
tration of a thrombolytic agent did not appear to accelerate
the time from MI onset to rupture or tamponade. In all,
75% of the patients who received thrombolytic therapy
developed rupture or tamponade within 47 h after MI.
Hemodynamic characteristics. No hemodynamic vari-
ables appeared to distinguish between patients with rupture
or tamponade and those without (Table 2). Systolic and
diastolic BPs, heart rate, right-heart pressures and cardiac
index values did not differ significantly between the two
groups, but patients with rupture or tamponade tended to
have higher a right atrial mean pressure and heart rate and
a lower pulmonary capillary wedge pressure (p , 0.20).
Echocardiographic findings. Of the 28 patients with rup-
ture or tamponade, 20 had echocardiograms, of which 15
(75%) showed a pericardial effusion. Most of these were
generalized effusions (67%), and the rest localized. The
location of the effusion did not correlate with MI location.
Right atrial or RV collapse was described in 39% of patients,
and a myocardial tear was seen in 39%.
Angiographic findings. There was no difference in the
distributions of the number of diseased vessels between
patients with rupture or tamponade (n 5 18) and those
without (n 5 578) (Table 3). There were significant
differences in the culprit vessel between patients with and
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without rupture (p 5 0.033); the left anterior descending or
circumflex artery was the culprit vessel more often in those
with rupture or tamponade. It is interesting that no patients
with rupture had the right coronary artery as the culprit
vessel versus 29.5% of the patients in the no-rupture group.
The proportion with TIMI grade 2 or 3 flow in the culprit
vessel did not differ significantly between groups.
Outcomes. Overall in-hospital survival in the rupture or
tamponade patients was 39.3%, which was identical to that
in the 1,020 patients without this complication. One patient
died 1.8 h after admission and did not undergo either
pericardiocentesis or surgery. Of the six patients who had
pericardiocentesis alone, 50% survived, and 38% of the 21
patients whom had surgical repair (with or without bypass
Table 1. Comparison of Clinical Features of Cardiac Rupture/Tamponade Patients and Other
Suspected Shock Patients Excluding Those With Mechanical Causes
Rupture/Tamponade
Present (n 5 28)
Rupture/Tamponade
Absent (n 5 1,020) p Value
Age (yrs) n 5 28 71.1 6 8.4 n 5 1020 68.4 6 12.1 0.233
Weight (lbs) 23 159.1 6 24.4 620 165.7 6 35.9 0.380
Female gender 28 53.6% 1020 37.8% 0.114
Transfers 28 53.6% 1020 42.2% 0.249
History of infarction 27 18.5% 980 39.3% 0.029
History of bypass surgery 27 3.7% 1003 10.2% 0.510
History of angioplasty 27 0.0% 984 6.4% 0.406
History of congestive heart failure 27 3.7% 978 21.0% 0.027
History of hypertension 27 55.6% 977 52.4% 0.846
Diabetes 27 14.8% 997 33.6% 0.040
History of elevated lipids 18 38.9% 513 41.9% 1.000
History of peripheral vascular disease 21 0.0% 651 18.6% 0.021
History of renal insufficiency 27 3.7% 969 11.7% 0.352
Cigarette smoking 21 52.4% 873 51.3% 1.000
Location of infarction
Anterior 28 53.6% 910 56.7% 0.847
Inferior 28 57.1% 909 44.7% 0.247
Posterior 28 21.4% 908 18.4% 0.626
Lateral 28 35.7% 910 32.1% 0.685
Apical 28 14.3% 911 10.3% 0.524
Multiple 28 60.7% 909 49.2% 0.254
New Q waves in .2 leads 27 51.9% 1009 31.5% 0.035
ST-segment elevation* 28 21.4% 1013 15.3% 0.422
New left bundle-branch block 28 0.0% 1014 10.0% 0.101
Ischemic event† 24 33.3% 727 19.0% 0.110
Pulmonary edema on exam 24 16.7% 732 55.3% , 0.001
Pulmonary edema on X-ray 24 45.8% 726 58.8% 0.214
Heart rate $60 per minute 24 87.5% 729 89.8% 0.728
*Postinfarction, post-Q-wave. †Between first MI and cardiogenic shock.
Table 2. Comparison of Hemodynamic Characteristics of Cardiac Rupture/Tamponade Patients
and Other Suspected Shock Patients Excluding Those With Mechanical Causes
Rupture/Tamponade Present
(n 5 28)
Rupture/Tamponade Absent
(n 5 1,020) p Value
Systolic blood pressure (mm Hg) n 5 24 85.8 6 24.4 n 5 966 88.0 6 22.8 0.64
Diastolic blood pressure (mm Hg) 17 54.1 6 20.8 843 52.2 6 17.3 0.66
Heart rate (beats/min) 23 105.5 6 29 965 95.0 6 26.4 0.06
Right atrial pressure (mm Hg) 14 18.0 6 7.8 320 14.7 6 7.7 0.12
Right ventricular systolic
pressure (mm Hg)
10 41.8 6 21.6 142 45.5 6 18.7 0.55
Right ventricular diastolic
pressure (mm Hg)
10 17.3 6 4.0 134 15.2 6 9.6 0.49
Pulmonary artery systolic
pressure (mm Hg)
17 39.9 6 19.1 391 41.0 6 12.5 0.73
Pulmonary artery diastolic
pressure (mm Hg)
16 20.6 6 6.2 393 24.0 6 8.0 0.09
Pulmonary capillary wedge
pressure (mm Hg)
18 20.8 6 7.3 611 23.6 6 8.5 0.17
Cardiac index (L/min/m2) 13 2.0 6 0.7 467 2.1 6 0.8 0.68
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surgery) survived. Survival in men was 54% (7/13) compared
with 27% (4/15) in women (p 5 0.246), the average age of
those surviving was 66 6 9.8 years compared with 74.6 6
5.3 years for patients not surviving (p 5 0.005). Data on the
timing of pericardiocentesis or surgical repair are not avail-
able.
DISCUSSION
Rupture of the free wall of the LV after acute MI often is a
catastrophic event. Its prevalence in the SHOCK Trial
Registry was 2.7%, but it is impossible to know the true
prevalence because many patients die immediately and the
cause of death is not confirmed. Lopez-Sendon et al. (16)
estimated the overall incidence of rupture at 6.2%, of which
about 30% presented subacutely. In their study, 29 of 1,453
patients (2%) had subacute rupture confirmed at operation,
and 94% of those patients presented with hypotension.
Considering that almost all patients with subacute rupture
present with CS, the Registry’s cohort of patients with this
condition represents an important addition to the literature.
Although rupture and tamponade were grouped for pur-
poses of our analysis, tamponade alone may represent
instances of spontaneously sealed or unrecognized rupture.
Serous or hemorrhagic effusions, however, can occur with-
out documented free-wall rupture; in the Lopez-Sendon
series, 6 of 1,214 patients presented this way, which is in
general agreement with the 9 of 1,048 patients seen in our
analysis.
Demographics of patients with rupture. The National
Registry of Myocardial Infarction found a higher mortality
from cardiac rupture in women than in men (6.8% vs. 3%)
after adjusting for age. In multivariate analysis of that series,
thrombolytic therapy and prior MI also were found to be
independent predictors of myocardial rupture (17). We
found a trend toward increased myocardial rupture in
women and older patients, but only age—not gender—is
associated with mortality in the SHOCK Trial Registry.
Administration of thrombolytics was not associated with a
higher rate of rupture in our series, and prior MI was found
less often in our patients with rupture than in those with CS
from other causes. It is interesting to speculate whether a
previous MI with scar formation or pericardial inflamma-
tion offers some degree of protection against rupture during
a later infarction. Diabetes and peripheral vascular disease
were also less prevalent in our patients with rupture or
tamponade; it is unknown whether these conditions predis-
pose patients to LV pump failure after MI (reflecting more
extensive coronary artery disease) or whether they protect
against rupture (via increased myocardial fibrosis). In a large
series of patients dying of rupture after undergoing throm-
bolysis for MI, Becker et al. (18) also found prior MI and
diabetes to be less frequent in patients with rupture than in
those succumbing primarily to left ventricular failure.
Hemodynamic, echocardiographic and angiographic fea-
tures. The hemodynamic profile of patients with rupture or
tamponade in our series did not differ significantly from that
of the larger group of patients in CS after MI. We did not
collect detailed information about whether typical hemody-
namic findings, such as a blunted Y descent or pulsus
paradoxus, were present, but other series have shown these
findings to be neither sensitive nor specific for the diagnosis
of tamponade in this setting (4,19). Pulmonary edema,
however, was noted in only 16.7% of our patients with
rupture or tamponade, compared with 55.3% of patients
without this complication. This may be a useful new clinical
indicator of rupture or tamponade.
The echocardiogram has obvious utility in the diagnosis
of rupture or tamponade. In the series of Lopez-Sendon, the
presence of pericardial effusion .5 mm was 100% sensitive
for the diagnosis of subacute ventricular-wall rupture (16).
It is difficult to explain why only 75% of our patients with
rupture or tamponade showed an effusion on echocardiog-
raphy. Perhaps the timing of the rupture or severity of the
clinical condition prevented the acquisition of technically
adequate images. Alternatively, perhaps some patients who
are prone to develop CS after rupture or tamponade have
small effusions, which are less easily detected by echocardi-
ography but may produce substantial hemodynamic effects.
The most interesting angiographic finding in our series
was that the right coronary artery was less often the culprit
vessel in patients with rupture or tamponade. Although
subacute free-wall rupture has been reported after right
coronary-artery occlusion, and inferior-wall location by
ECG is well represented in patients with rupture, right
coronary-artery occlusion more often may lead to rupture of
the lower ventricular septum, with development of ventric-
ular septal defect (20,21). The number of patients with
rupture or tamponade in our series whose culprit artery was
Table 3. Comparison of Angiographic Characteristics* of
Cardiac Rupture Patients and Other Suspected Shock Patients
Excluding Those With Mechanical Causes
Rupture/
Tamponade
Present
(n 5 19)
Rupture/
Tamponade
Absent
(n 5 618)
p
Value
Number of diseased vessels
(n 5 18, n 5 592)
0.194
0 0% 1.0%
1 33.3% 21.1%
2 33.3% 21.6%
3 33.3% 56.3%
Left main disease
(n 5 18, n 5 578)
11.1% 16.4% 0.751
Culprit vessel (n 5 12, n 5 471) 0.033
Left anterior descending 66.7% 42.3%
Right coronary 0% 29.5%
Circumflex 33.3% 14.0%
Left main 0% 5.9%
Bypass graft 0% 8.3%
TIMI grade 2 or 3 flow
in the culprit vessel
(n 5 11, n 5 396)
36.4% 31.6% 0.748
*For patients with angiographic data.
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known, however, was small (12/28); this observation may
represent random variation.
Clinical outcomes after rupture. The overall survival of
patients with rupture or tamponade was identical to that of
patients with CS secondary to primary pump failure
(39.3%). All but one of the patients with rupture or
tamponade had either pericardiocentesis alone or surgical
evacuation and repair, which should be considered the
standard of care for this condition (22–25). This overall
survival rate compares favorably with the 48.5% long-term
survival reported by Lopez-Sendon et al. (16). The slightly
better long-term results in that series may reflect the lower
mean age of their patients (67.8 vs. 71.1 years). In any event,
a sizable proportion of patients with rupture or tamponade
present subacutely, which provides an opportunity for diag-
nosis and effective treatment.
Study limitations. The small number of patients with
cardiac rupture or tamponade prevents detailed analysis of
treatment approaches or predictors of survival. Furthermore,
due to the low prevalence of this condition, the tamponade
cohort in this Registry is small, and thus, the primary intent
of this report is descriptive rather than comparative. Ac-
cordingly, no adjustments were made for multiple univariate
comparisons. The multicenter organization of the Registry
precluded a uniform approach to diagnosis and treatment
and, therefore, restricts our ability to determine the sensi-
tivity and specificity of clinical findings and diagnostic
methods. Because echocardiography was not performed
uniformly and serially in all patients, we may have under-
estimated the true incidence of rupture or tamponade.
Finally, we grouped rupture and tamponade for purposes of
analysis. Although tamponade alone may reflect patients
with spontaneously sealed rupture or hemorrhagic inflam-
mation, it also could reflect a different, potentially more
benign, etiology (26,27).
Conclusions. Cardiac rupture or tamponade was found in
2.7% of the patients developing CS after MI. Survival after
appropriate diagnosis and treatment was no different from
that of the overall cohort of patients in CS after MI; thus,
rapid diagnosis is crucial if there is to be any opportunity for
life-saving intervention. Diabetes, prior MI, and peripheral
vascular disease were significantly less prevalent in patients
developing rupture or tamponade, and pulmonary edema
was found less frequently upon physical examination
compared with shock patients without rupture or tam-
ponade. Hemodynamic variables did not distinguish the
two groups, but echocardiography was useful in making
the diagnosis and should be obtained quickly in all
patients developing hypotension after MI.
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